Advanced therapeutic strategies targeting microglia: beyond neuroinflammation.
- Published in:
- Archives of Pharmacal Research, 2022, v. 45, n. 9, p. 618, doi. 10.1007/s12272-022-01406-1
- By:
- Publication type:
- Article
Works matching IS 02536269 AND DT 2022 AND VI 45 AND IP 9
Results: 5
1
2
Caffeic acid phenethyl ester inhibits pseudo-allergic reactions via inhibition of MRGPRX2/MrgprB2-dependent mast cell degranulation.
- Published in:
- Archives of Pharmacal Research, 2022, v. 45, n. 9, p. 644, doi. 10.1007/s12272-022-01405-2
- By:
- Publication type:
- Article
3
Inhibitory effects of 6′-sialyllactose on angiotensin II-induced proliferation, migration, and osteogenic switching in vascular smooth muscle cells.
- Published in:
- Archives of Pharmacal Research, 2022, v. 45, n. 9, p. 658, doi. 10.1007/s12272-022-01404-3
- By:
- Publication type:
- Article
4
Predictive biomarkers for molecularly targeted therapies and immunotherapies in breast cancer.
- Published in:
- Archives of Pharmacal Research, 2022, v. 45, n. 9, p. 597, doi. 10.1007/s12272-022-01402-5
- By:
- Publication type:
- Article
5
Structures, biomimetic synthesis, and anti-SARS-CoV-2 activity of two pairs of enantiomeric phenylpropanoid-conjugated protoberberine alkaloids from the rhizomes of Corydalis decumbens.
- Published in:
- Archives of Pharmacal Research, 2022, v. 45, n. 9, p. 631, doi. 10.1007/s12272-022-01401-6
- By:
- Publication type:
- Article